Detalhe da pesquisa
1.
Stem cell dynamics and cellular heterogeneity across lineage subtypes of castrate resistant prostate cancer.
Stem Cells
; 2024 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38563224
2.
High-Grade, Nonsarcomatoid Chromophobe Renal Cell Carcinoma: A Series of 22 Cases With Novel Molecular Features on a Subset.
Mod Pathol
; 37(5): 100472, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38492778
3.
A novel prostate cancer subtyping classifier based on luminal and basal phenotypes.
Cancer
; 129(14): 2169-2178, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37060201
4.
ERG Status at the Margin Is Associated With Biochemical Recurrence After Radical Prostatectomy With Positive Surgical Margins.
Mod Pathol
; 36(7): 100147, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36828362
5.
Predicting Prostate Cancer Molecular Subtype With Deep Learning on Histopathologic Images.
Mod Pathol
; 36(10): 100247, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37307876
6.
GPNMB expression identifies TSC1/2/mTOR-associated and MiT family translocation-driven renal neoplasms.
J Pathol
; 257(2): 158-171, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35072947
7.
P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer.
J Pathol
; 256(2): 149-163, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34652816
8.
Clinical and genomic features of SPOP-mutant prostate cancer.
Prostate
; 82(2): 260-268, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34783071
9.
Localization of macrophage subtypes and neutrophils in the prostate tumor microenvironment and their association with prostate cancer racial disparities.
Prostate
; 82(16): 1505-1519, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35971807
10.
Association of B7-H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer.
Cancer
; 128(12): 2269-2280, 2022 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35333400
11.
Association between pathogenic germline mutations in BRCA2 and ATM and tumor-infiltrating lymphocytes in primary prostate cancer.
Cancer Immunol Immunother
; 71(4): 943-951, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34533610
12.
Differential mast cell phenotypes in benign versus cancer tissues and prostate cancer oncologic outcomes.
J Pathol
; 253(4): 415-426, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33338262
13.
Reciprocal YAP1 loss and INSM1 expression in neuroendocrine prostate cancer.
J Pathol
; 255(4): 425-437, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34431104
14.
Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair-Deficient Prostate Cancer.
Oncologist
; 26(2): e270-e278, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33215787
15.
Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer.
Mod Pathol
; 34(6): 1185-1193, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33462368
16.
PIN-like ductal carcinoma of the prostate has frequent activating RAS/RAF mutations.
Histopathology
; 78(2): 327-333, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32740981
17.
[Molecular pathology of urogenital tumors : Recommendations from the 2019 International Society of Urological Pathology (ISUP) Consensus Conference]. / Molekularpathologie bei urologischen Tumoren : Empfehlungen der Konsenskonferenz der Internationalen Gesellschaft für Uropathologie (ISUP) 2019.
Pathologe
; 42(3): 310-318, 2021 May.
Artigo
em Alemão
| MEDLINE | ID: mdl-33398501
18.
Germline BLM mutations and metastatic prostate cancer.
Prostate
; 80(2): 235-237, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31816118
19.
Neuroendocrine differentiation in usual-type prostatic adenocarcinoma: Molecular characterization and clinical significance.
Prostate
; 80(12): 1012-1023, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32649013
20.
Genomic and clinical characterization of stromal infiltration markers in prostate cancer.
Cancer
; 126(7): 1407-1412, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31905251